Corporate Announcements
April, 2014
Quarterly Activities Report: March 2014
February, 2014
Appendix 3B - Quotation of Additional Securities and Agreement
iSonea Takes Next Steps to Commercialise Asthma Management Technology
January, 2014
iSonea’s Asthma Technology Awarded at International CES Conference
Appendix 3B - Application for Quotation of Additional Securities and Agreement
Appendix 3X - Initial Director’s Interest Notice
Appendix 3Z - Final Director’s Interest Notice
iSonea Announces Board of Director and Management Changes
December, 2013
iSonea To Drive Aggressive AirSonea™ Sales Plan in Australia
Change of Director’s Interests, Washer
New Issue Announcement, Application for Quotation of Additional Securities and Agreement
November, 2013
New Issue Announcement, Application for Quotation of Additional Securities and Agreement
iSonea Technology Featured on National Television Program
October, 2013
Procter & Gamble’s TREMOR™ to Promote AirSonea™ to Women
iSonea CEO to Present at Australian Biotech Investment Conference
Application for Additional Securities and Agreement
iSonea Chairman to Present at Prestigious Australian Medical Conference
iSonea Partners with uHealth to Distribute AirSonea Technology via Pharmacies
iSonea CEO to Present at Prestigious International Mobile Health Conference
Application for Additional Securities and Agreement
Notice of Annual General Meeting and Explanatory Memorandum
iSonea releases Annual Report for 2013
Application for Additional Securities and Agreement
September, 2013
iSonea Launches Mobile Health Technology AirSonea™
Application for Additional Securities
iSonea Achieves CE Mark for AirSonea™
Appendix 3B: Announcement for application for quotation of additional securities
August, 2013
iSonea Releases Preliminary Annual Report
iSonea Receives Prestigious Innovation Award
Appendix 3B: Announcement for application for quotation of additional securities
ISN ASX Confirm AirSonea TGA Listing
iSonea Achieves Therapeutic Goods Administration Listing for AirSonea
July, 2013
Recently Released: Quarterly Report - June 2013
Appendix 3B: Exercise of Options
New Issue Announcement for Quotation of Additional Securities and Agreement
Investor Presentation: July 2013
iSonea Completes $13.5M Private Placement
Notice of Change of Interests of Substantial Holder
June, 2013
iSonea Raises $13.5 million via Private Placement
iSonea Selects International Manufacturing Partner to Scale Up
AirSonea™ Production
Physicians Overwhelmingly Support AirSonea™
May, 2013
Appendix 3B - New Issue Announcement
April, 2013
Quarterly Activities Report - 31 March 2013
iSonea CEO to Present at Investor Forum
New Issue of iSonea Newsletter Available
New issue announcement, application for quotation of additional securities and agreement
Change of Director’s Interest Notice
iSonea Launches New Asthmasense™ Cloud Technology
March, 2013
iSonea to Unveil New Asthma Technology at Australian Asthma Conference
iSonea Unveils Regulatory Plans for AirSonea™ Wheeze Monitor
February, 2013
Dr. Stewart Washer Presentation to BioMelbourne Mobile Health Conference
Change of Director’s Interest Notice
January, 2013
iSonea Chairman to Present at BioMelbourne Mobile Health Conference
iSonea Limited Announces Free Issuance Period for Conversion of KMLXF Shares to ISOAY ADRs
December, 2012
iSonea Previews AsthmaSense v1.1 at mHealth Summit
November, 2012
Results of Annual General Meeting
Change of Director’s Interest Notice: Washer
Change of Director’s Interest Notice: Dantzker
Change of Director’s Interest Notice: Korten
Change of Director’s Interest Notice: Haghighat
Change of Director’s Interest Notice: MacDonald
October, 2012
ISN ASX Confirm Rights Issue Shortfall
Notice of Annual General Meeting and Explanatory Memorandum
Dispatch of Renounceable Pro-Rate Rights Issue Prospectus
iSonea Files FDA Submission for Over-the-Counter SonoSentry™
September, 2012
Letter to Eligible Shareholders on Rights Issue
Letter to Ineligible Shareholders on Rights Issue
iSonea Announces Fully Underwritten Renounceable Rights Issue to Raise $4M
Appendix 3B: application for quotation of additional securities and agreement
Prospectus: Offer to Eligible Shareholders
August, 2012
Notice of Initial Substantial Holder
Bruce Mathieson Becomes Cornerstone Investor of iSonea
Application for Quotation of Additional Securities and Agreement
Change of Director’s Interest Notice, Washer
Change of Director’s Interest Notice, Haghighat
Change of Director’s Interest Notice, Dantzker
Change of Director’s Interest Notice, Korten
Change of Director’s Interest Notice, Washer
iSonea Completes Capital Consolidation
Isonea run successful App trial in Memphis
iSonea Launches Updated AsthmaSense™ Smartphone App for Global Market
Change of Director’s Interest Notice
July, 2012
iSonea Announces Results of General Meeting
General Meeting Presentation by Micheal Thomas: Value Appreciation Via Sound Asthma Management
iSonea Announces New Chairman of the Board
June, 2012
Updated Capital Consolidation Timetable
OzEquities Analyst Report: Isonea Has Market Leading Asthma Monitoring Products …
iSonea Launches First Mobile Asthma Technology
Archived ASX, Investor and Corporate Announcements